Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Fenamates: A Novel Class of Reversible Gap Junction Blockers

Erik G. A. Harks, Albert D. G. de Roos, Peter H. J. Peters, Laura H. de Haan, Abraham Brouwer, Dirk L. Ypey, Everardus J. J. van Zoelen and Alexander P. R. Theuvenet
Journal of Pharmacology and Experimental Therapeutics September 2001, 298 (3) 1033-1041;
Erik G. A. Harks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert D. G. de Roos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter H. J. Peters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura H. de Haan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abraham Brouwer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk L. Ypey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Everardus J. J. van Zoelen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander P. R. Theuvenet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effect of fenamates on gap junctional intercellular communication was investigated in monolayers of normal rat kidney (NRK) fibroblasts and of SKHep1 cells overexpressing the gap junction protein connexin43 (Cx43). Using two different methods to study gap junctional intercellular communication, single electrode voltage-clamp step response measurements and dye microinjection, we show that fenamates are reversible blockers of Cx43-mediated intercellular communication. After adding fenamates to a confluent monolayer of electrically coupled NRK fibroblasts, the voltage step-induced capacitive current transient changed from a transient characteristic for charging multiple coupled cell capacitances to one characteristic for a single cell in isolation. The capacitance of completely uncoupled cells was 19.7 ± 1.0 pF (mean ± S.E.M.; n = 11). Junctional conductance between the patched cell and the surrounding cells in the monolayer changed from >140.7 ± 9.6 nS (mean ± S.E.M.;n = 14) to <1.4 ± 0.4 nS (mean ± S.E.M.; n = 11) after uncoupling. Electrical coupling could be restored to >51.8 ± 4.2 nS (mean ± S.E.M.; n = 11) by washout of the fenamates. Voltage-clamp step response measurements showed that the potency of fenamates in inhibiting electrical coupling decreases in the order meclofenamic acid > niflumic acid > flufenamic acid. The half-maximal concentration determined by dye-coupling experiments was 25 and 40 μM for meclofenamic acid and flufenamic acid, respectively. Inhibition of gap junctional communication by fenamates did not involve changes in intracellular calcium or pH, and was unrelated to protein kinase C activity or an inhibition of cyclooxygenase activity. Voltage-clamp step response measurements in confluent monolayers of SKHep1 cells that had been stably transfected with Cx43 revealed that fenamates are potent blockers of Cx43-mediated intercellular communication. In conclusion, fenamates represent a novel class of reversible gap junction blockers that can be used to study the role of Cx43-mediated gap junctional intercellular communication in biological processes.

Footnotes

  • ↵1 Current address: Swammerdam Institute for Life Sciences, Faculty of Science, University of Amsterdam, The Netherlands.

  • ↵2 Current address: Institute of Environmental Studies, Department of Chemistry, Toxicology and Ecology, Free University of Amsterdam, The Netherlands.

  • Abbreviations:
    NRK
    normal rat kidney
    GJIC
    gap junctional intercellular communication
    Cx43
    connexin43
    PKC
    protein kinase C
    DMEM
    Dulbecco's modified Eagle's medium
    MFA
    meclofenamic acid
    FFA
    flufenamic acid
    TPA
    12-O-tetradecanoylphorbol-13-acetate
    • Received January 31, 2001.
    • Accepted May 8, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 298 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 298, Issue 3
1 Sep 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Fenamates: A Novel Class of Reversible Gap Junction Blockers
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Fenamates: A Novel Class of Reversible Gap Junction Blockers

Erik G. A. Harks, Albert D. G. de Roos, Peter H. J. Peters, Laura H. de Haan, Abraham Brouwer, Dirk L. Ypey, Everardus J. J. van Zoelen and Alexander P. R. Theuvenet
Journal of Pharmacology and Experimental Therapeutics September 1, 2001, 298 (3) 1033-1041;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Fenamates: A Novel Class of Reversible Gap Junction Blockers

Erik G. A. Harks, Albert D. G. de Roos, Peter H. J. Peters, Laura H. de Haan, Abraham Brouwer, Dirk L. Ypey, Everardus J. J. van Zoelen and Alexander P. R. Theuvenet
Journal of Pharmacology and Experimental Therapeutics September 1, 2001, 298 (3) 1033-1041;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Assessment of Fenamate-Induced Electrical Uncoupling of NRK Cells in a Monolayer with Use of an Electrical Equivalent Circuit.
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Chlorogenic Acid Inhibits Breast Cancer Metastasis
  • SNAP25 and mGluRs Control Pathological Tau Release
  • N-Stearoylethanolamine Inhibits Platelet Reactivity
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics